A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function

Area of Science:

• Clinical Chemistry
• Immunodiagnostics
• Renal Medicine

Background:

• Serum free light chain (sFLC) assays are crucial for diagnosing monoclonal gammopathies (MG).
• Current interpretation relies on manufacturer-defined reference intervals, which are inaccurate in patients with renal impairment, leading to high false positive rates.
• Existing renal-specific intervals face practical limitations, necessitating a more robust interpretation method.

Purpose of the Study:

• To develop and validate renally robust interpretation methods for sFLC assays.
• To address the limitations of current sFLC interpretation in patients with varying renal function.
• To improve the diagnostic accuracy of sFLC assays in the presence of renal impairment.

Main Methods:

• Retrospective data mining was employed to establish patient cohorts reflecting diverse renal function.
• Two novel reference intervals were developed for the FREELITE assay on a Roche Cobas c501 instrument: one sFLC-ratio-based and one principal component analysis (PCA)-based.
• The performance of these new intervals was compared against the manufacturer's reference interval.

Main Results:

• Both novel interpretation methods demonstrated significantly lower false positive rates compared to the manufacturer's interval.
• The new methods showed greater robustness to variations in renal function.
• Sensitivity for diagnosing monoclonal gammopathy (MG) was maintained equivalently across all methods, with a slightly higher point estimate for the PCA-based approach.

Conclusions:

• Renally robust sFLC interpretation is achievable with a single reference interval derived from a representative patient cohort.
• The developed methods offer practical advantages by eliminating the need for estimated glomerular filtration rate (eGFR) or multiple intervals.
• Further research is warranted to confirm the potential superior sensitivity of the PCA-based metric for MG diagnosis.